Biliary Atresia is a devastating pediatric cholangiopathy affecting the bile ducts of the liver. In
this review, we describe recent progress in the understanding of liver development with a …

Background The quality of life of patients with Biliary Atresia (BA) have not been
systematically examined. The goal of this meta-analysis is to determine patients' …

Biliary atresia, a fibro-obliterative disease of the newborn, is usually initially treated by Kasai
portoenterostomy, although there are many variations in technique and different options for …

Because the human eye cannot visually detect the results of direct bilirubin test papers
accurately and quantitatively, this study proposes four different highly collimated mini light …

Abstract Background Biliary Atresia (BA), an obstructive cholangiopathy, is the most
common cause of end-stage liver disease and liver transplantation in children. Timely …

Background Biliary atresia (BA) is an intractable disease of unknown cause that develops in
the neonatal period. It causes jaundice and liver damage due to the destruction of …

Background Biliary atresia (BA) is a severe hepatobiliary disease in infants that ultimately
results in hepatic failure; however, its pathological mechanism is poorly elucidated. Current …

Background Experience with transjugular intrahepatic portosystemic shunts (TIPS) in the
pediatric population, especially in infants, is limited. Objective To evaluate the feasibility …

Background. Biliary atresia (BA) is a devastating congenital disease characterized by
inflammation and progressive liver fibrosis. Activation of hepatic stellate cells (HSCs) plays a …

Background Timing for liver transplantation (LT) in biliary atresia (BA) children with end-
stage liver disease (ESLD) is associated with all-cause mortality. The cut-off value of …